AKR1B1 and diabetes mellitus: Since a current treatment method for diabetes is the inhibition of enzymes involved in the hydrolysis of carbohydrates in the digestive tract, in vitro studies are being conducted on the inhibition of diabetic enzymes (i.e. α-amylase, α-glucosidase, aldose reductase) [14,17,18].